
    
      This protocol is designed to screen patients with suspected or identified genetic diseases of
      immune cell homeostasis, reflecting abnormalities in programmed cell death, survival,
      development, activation, and/or proliferation. Patients determined by clinical history and
      initial outside evaluation by their referring physician to be of interest will be consented
      and enrolled into this study. Blood and other biological specimens from patients or their
      family members will be obtained for research studies related to understanding the genetic and
      biochemical bases of these diseases. Outside medical records will be obtained for chart
      review to correlate clinical history to research laboratory testing results. Results will be
      relayed to the referring physicians and, where applicable, patients will be referred to other
      relevant research studies at the NIH.

      The study will enroll up to 5000 patients and family members over the next 10 years.
    
  